NCT04117295 - Carmat TAH Early Feasibility Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

January 31, 2027

Conditions

End-stage Heart Failure

Interventions

DEVICE

Carmat Total Artificial Heart

Heart replacement therapy

Trial Locations (4)

VCU Medical Center, Richmond

Duke University Medical Center, Durham

University of Louisville Jewish Hospital, Louisville

Baylor University Medical Center, Dallas